COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 944: Articles 9431-9440  | Next

SARS-CoV-2 and influenza co-infection throughout the COVID-19 pandemic: An assessment of co-infection rates and cohort characterization
Pawlowski, C., Silvert, E., O'Horo, J. C., Lenehan, P. J., Challener, D. W., Gnass, E., Murugadoss, K., Ross, J., Speicher, L., Geyer, H., Venkatakrishnan, A. J., Badley, A., Soundararajan, V.
10.1101/2022.02.02.22270324 — Posted: 2022-02-05
A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021
Adamson, J. P., Smith, C., Pacchiarini, N., Connor, T. R., Wallsgrove, J., Coles, I., Frost, C., Edwards, A., Moore, C., Sinha, J., Perrett, S., Craddock, C., Sawyer, C., Waldram, A., Barrasa, A., Thomas, D. R., Daniels, P., Lewis, H.
10.1101/2022.02.02.22269960 — Posted: 2022-02-05
Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam
Dang, A. D., Vu, T. D., Vu, H. H., Ta, V. T., Pham, A. T. V., Dang, M. T. N., Le, B. V., Duong, T. H., Nguyen, D. V., Lawpoolsri, S., Chinwangso, P., McLellan, J. S., Hsieh, C.-L., Garcia-Sastre, A., Palese, P., Sun, W., Martinez, J. L., Gonzalez-Dominguez, I., Slamanig, S., Carreno, J. M., Tcheou, J., Krammer, F., Raskin, A., Vu, H. M., Tran, T. C., Nguyen, H. M., Mercer, L. D., Raghunandan, R., Lal, M., White, J. A., Hjorth, R., Innis, B. L., Scharf, R.
10.1101/2022.02.01.22270253 — Posted: 2022-02-05
Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19.
Bishop, C. W., Ashfaq, A., Melnick, J. Z., Vazquez-Escarpanter, E., Fialkow, J. A., Strugnell, S. A., Choe, J., Kalantar-Zadeh, K., Federman, N. C., Ng, D., Adams, J. S.
10.1101/2022.01.31.22270036 — Posted: 2022-02-05
Estimation and interpretation of vaccine efficacy in COVID-19 randomized clinical trials
Michiels, H., Vandebosch, A., Vansteelandt, S.
10.1101/2022.02.02.22270317 — Posted: 2022-02-05
Increase in coercive measures in psychiatric hospitals in Germany during the COVID-19 Pandemic
Steinert, T., Hirsch, S., Eisele, F., Flammer, E.
10.1101/2022.02.03.22270373 — Posted: 2022-02-05
Chronic fatigue associated with post-COVID syndrome versus transient fatigue caused by high intensity exercise: are they comparable in terms of vascular effects?
Chudzik, M., Cender, A., Mordaka, R., Zielinski, J., Katarzynska, J., Marcinek, A., Gebicki, J.
10.1101/2022.02.03.22270294 — Posted: 2022-02-05
Humoral Antibody Kinetics with ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) Vaccine among Indian Healthcare workers: A 6-month Longitudinal Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) Study
SINGH, A. K., Phatak, S. R., Singh, R., Bhattacharjee, K., Singh, N. K., Gupta, A., Sharma, A.
10.1101/2022.02.03.22270182 — Posted: 2022-02-05
Comprehensive analysis of next-generation sequencing data in COVID-19 and its secondary complications
Vastrad, B. M., Vastrad, C. M.
10.1101/2022.02.03.478930 — Posted: 2022-02-04
Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada
Piche-Renaud, P.-P., Panetta, L., Farrar, D. S., Moore-Hepburn, C., Drouin, O., Papenburg, J., Salvadori, M. I., Kakkar, F., Morris, S. K.
10.1101/2022.02.02.22270334 — Posted: 2022-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).